tirzepatide eye Use of the dual GIP/GLP-1 drug (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort GLP-1 Medications and Your Vision:

In todays competitive aesthetic market, informed decisions are not optionalthey are essential.

Skin brightening requires the longest commitment, with most people needing consistent twice-weekly sessions over four to six weeks before noticing visible changes

Take SEMBOLIC 14 TABLET in the morning on an empty stomach, at least 30 minutes before consuming food, beverages, or other medications

You should hear a click, followed by a second click, 10 to 15 seconds later once the injection has finished

otherwise, patients should skip that dose and resume the regular schedule

Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis. EClinicalMedicine, 2025